Reaksi Drug Safety News 2017 - Issue 5/2017 Print User Rating: 1 / 5 Please Rate Vote 1 Vote 2 Vote 3 Vote 4 Vote 5 Reaksi Drug Safety News 2017, Issue 5/2017 Vemurafenib: Risk of Dupuytren’s Contracture and Plantar Fascial Fibromatosis Leflunomide and Teriflunomide: Risk of Falsely Decreased Ionised Calcium Levels and Risk of Colitis DOWNLOAD PDF